Is this normal aging, or could it indicate dementia? According to experts, the answer is often reassuring, but context and patterns matter.

Lithium-a decades-old treatment for bipolar disorder-may hold potential neuroprotective benefits beyond mood stabilization.

A clinical trial suggests that low-dose lithium may slow the decline of verbal memory in older adults with mild cognitive impairment and amyloid-beta.

Lithium—a decades-old treatment for bipolar disorder—may hold potential neuroprotective benefits beyond mood stabilization.

Researchers at Johns Hopkins Medicine may have discovered an unexpected new approach. They have been studying a drug that was originally developed for completely different diseases, including ...

For too long, the promise of personalized therapies has been tantalizingly close, yet frustratingly out of reach for ...

Obesity leaves a lasting imprint on fat and immune cells in ways that might make weight regain harder to avoid ...

Medical researchers have examined what can happen when patients feel their symptoms are dismissed. According to a May 2025 review from Rutgers Health, published in Psychological Bulletin, so-called ...

Scientists have zeroed in on a critical weak spot behind a rare but devastating brain autoimmune disorder often known as ...

Novo Nordisk slashes U.S. prices for Ozempic and Wegovy by up to 50%, reshaping access to diabetes and weight-loss care.

Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...

In the hunt to ward off dementia, research out of the UK this week looked to assess whether existing drugs could be repurposed to fight the memory-robbing illness.